Utility of maternal A1c measurement in the second trimester for the diagnosis of gestational diabetes mellitus
- PMID: 40165123
- PMCID: PMC11956492
- DOI: 10.1186/s12884-025-07389-3
Utility of maternal A1c measurement in the second trimester for the diagnosis of gestational diabetes mellitus
Abstract
Background: To investigate the effectiveness of maternal hemoglobin A1c (HbA1c) in the diagnosis of gestational diabetes mellitus (GDM) in the second trimester.
Methods: A total of 3000 pregnant women between 24 and 28 weeks of gestation were included in the study. Screening for gestational diabetes was performed using maternal HbA1c in 1200 pregnant women who either refused or could not tolerate the OGTT. The HbA1c value for the diagnosis of GDM was set at ≥ 5.7% in accordance with a meta-analysis by Paula B. Renz et al. A total of 154 pregnant women with HbA1c ≥ 5.7% were diagnosed with gestational diabetes, and their data were recorded prospectively. These data were compared with obstetric outcomes in 250 pregnant women diagnosed with diabetes by performing a 100-g OGTT after a 50-g glucose challenge test (GCT).
Results: There were no significant differences between two groups in terms of maternal age, gestational age at diagnosis, gravidity, and parity. Body mass index (BMI) was found to be significantly higher in pregnant women with HbA1c levels ≥ 5.7% (p < 0.001). Polyhydramnios was more common in the HbA1c ≥ 5.7% group and oligohydramnios was more common in the OGTT group (p < 0.001). Neonatal hypoglycemia was found to be significantly higher in the OGTT group (p < 0.05). The median HbA1c value were different in each group (OGTT group 5.6%, HbA1c group 5.8%; p < 0.001).
Conclusion: HbA1c testing has lower accuracy rates than OGTT in diagnosing GDM because it may miss diagnosis in some groups.
Keywords: Gestational diabetes mellitus; HbA1c; Oral glucose tolerance test; Poor obstetric outcome.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Ethical approval was obtained by the institutional review board from Ankara Etlik Zubeyde Hanım Women's Health Training and Research Hospital on . The study complied with the ethical principles for medical research of the Declaration of Helsinki 09.06.2021 # 2021/63. Consent for publication: Not applicable. Informed consent: A verbal and written informed consent was obtained from all participants. Competing interests: The authors declare no competing interests.
Figures
References
-
- American Diabetes Association. 13. Management of diabetes in pregnancy. Diabetes care. 2017;40(Suppl 1):S114–S119. 10.2337/dc17-S016. PMID: 27979900. - PubMed
-
- ACOG Practice Bulletin No. 190: Gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):e49-e64. 10.1097/AOG.0000000000002501. PMID: 29370047. - PubMed
-
- American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–27. 10.2337/dc18-S002. PMID: 29222373. - PubMed
-
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel; Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva Ad, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y, Schmidt MI. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82. 10.2337/dc09-1848. PMID: 20190296 - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical